×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Avalo Therapeutics (AVTX) Surges 270% in a Week: Here's Why
Yahoo Finance
Avalo (AVTX) surges on adding a new pipeline drug, which has its origins at Eli Lilly. Alongside the acquisition, it also secured funding to...
1 month ago
Why Is Avalo Therapeutics (AVTX) Stock Up 326% Today?
InvestorPlace
Avalo Therapeutics stock is up with heavy trading of AVTX shares are completing its acquisition of AlmataBio and securing new funding.
1 month ago
Public equity report: Avalo gets makeover with PIPE, acquisition
BioCentury
A PIPE refreshed Avalo's balance sheet as it prepares to move forward a newly acquired program for an inflammatory skin disorder,...
1 month ago
Avalo Therapeutics Clears Key Benchmark, Hitting 90-Plus RS Rating
Investor's Business Daily
On Thursday, Avalo Therapeutics (AVTX) received a positive adjustment to its Relative Strength (RS) Rating, from 89 to 93.
2 weeks ago
REX American Resources Reports Upbeat Earnings, Joins Avalo Therapeutics, RH And Other Big Stocks Moving ...
markets.businessinsider.com
Avalo Therapeutics, Inc. (NASDAQ:AVTX) shares gained 430% to $25.35 after the company announced it acquired a Phase 2-ready anti-IL-1β mAb,...
1 month ago
Avalo signals change in fortunes by snapping up AlmataBio for ex-Lilly inflammatory drug
Fierce Biotech
Avalo Therapeutics is handing over more than $22 million in stock and cash to acquire AlmataBio for a phase 2-ready monoclonal antibody for...
1 month ago
Cambyz Golestaneh Just Bought 4.0% More Shares In Avalo Therapeutics, Inc. (NASDAQ:AVTX)
Yahoo News New Zealand
Potential Avalo Therapeutics, Inc. ( NASDAQ:AVTX ) shareholders may wish to note that insider Cambyz Golestaneh...
1 day ago
Novartis, Ono Latest to Announce Billion-Dollar M&A Deals
BioSpace
Follow along as BioSpace keeps you up to date on the latest pharma and biotech M&As, from announcements to closings.
1 week ago
Avalo Therapeutics Appoints Biotech Leaders to Board of Directors
GlobeNewswire
Appointments include industry veterans Aaron Kantoff, Jonathan Goldman, and Samantha Truex as Independent DirectorsBoard of Director...
1 month ago
Avalo Therapeutics' Newly Acquired Ex-Eli Lilly Drug Could Stand Out In Competitive Hidradenitis Suppurat
Benzinga
Unlock the potential of Avalo Therapeutics with AVTX-009, a promising drug for hidradenitis suppurativa. Oppenheimer upgrades to Outperform,...
3 weeks ago